Statistics for Avanos Medical (id:9554 AVNS)

Valuation metrics

Market cap

832.74M

Enterprise value

972.48M

Trailing P/E (ttm)

38.55

Forward P/E

10.85

PEG ratio

10.85

Price/Sales (ttm)

1.22

Price/Book (mrq)

0.68

Enterprise Value/Revenue

1.43

Enterprise Value/EBITDA

9.52

Overview

Shares outstanding

45.96M

Float

41.88M

Shares short

607.19K

% Held by insiders

0.03%

% Held by institutions

0.96%

Average volume (10 days)

306.55K

Average volume (90 days)

Price summary

52-Week low

17.39

52-Week high

25.36

52-Week change

-16.08%

Beta

0.92

50-Day moving average

22.30

200-Day moving average

20.87

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

2.30%

Operating margin

9.68%

Operational effectiveness

Return on assets

2.08%

Return on equity

1.77%

Income statement

Revenue (ttm)

14.79

Revenue per share (ttm)

14.79

Quarterly revenue growth (yoy)

Gross profit (ttm)

379.70M

EBITDA

84.70M

Net income to common (ttm)

21.70M

Diluted EPS (ttm)

0.47

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

89.00M

Total cash per share (mrq)

1.94

Total debt (mrq)

202.20M

Total Debt/Equity (mrq)

16.44

Current ratio (mrq)

222.00%

Book value per share (mrq)

26.73

Cash flow

Cash flow statement

55.50M

Levered free cash flow (LFCF)

140.15M